MedPath

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Phase 3
Terminated
Conditions
Carcinoma, Non-Small-Cell Lung
Lung Cancer
Neoplasms, Lung
Neoplasms, Pulmonary
Registration Number
NCT00290017
Lead Sponsor
Point Therapeutics
Brief Summary

This Phase 3 study will compare the efficacy of talabostat plus pemetrexed to pemetrexed plus placebo in patients with Stage IIIB/IV NSCLC who have failed a platinum-based chemotherapy regimen.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Men or women age ≥18 years
  • Histologically or cytologically confirmed NSCLC (Recurrent, locally advanced or metastatic, inoperable NSCLC [Stage IIIB/IV]. Patients with Stage IIIB NSCLC must have a cytologically documented pleural effusion.)
  • Failed or relapsed after receiving a platinum-containing chemotherapy regimen as first-line therapy for advanced NSCLC
  • Measurable disease on computerized tomography (CT) scan
  • ECOG Performance Status of 0 or 1
  • Expected survival ≥12 weeks
  • Provide written informed consent
Exclusion Criteria
  • More than 2 prior chemotherapy regimens
  • Progression of disease on prior pemetrexed treatment
  • Brain metastases (exception: patients who had a resection and/or completed a course of cranial irradiation, have no worsening CNS symptoms, and have discontinued all corticosteroids for that indication for at least 1 month)
  • Serum creatinine ≥2.0mg/dL or creatinine clearance <45mL/min
  • Absolute neutrophil count <1500/μL or platelets <100,000/μL
  • Any malignancy within 5 years immediately prior to the first dose of study medication (exception: basal cell or non-metastatic squamous cell carcinoma of the skin, and carcinoma in-situ of the cervix)
  • Any comorbidity or condition which, in the opinion of the investigator, may interfere with the assessments and procedures of this protocol
  • Patients who are within 28 days of chemotherapy, radiation therapy, immunotherapy, or investigational medication for NSCLC. Patients must have recovered from all of the side effects of treatment.
  • Pregnancy or lactation. Women of childbearing potential and non-vasectomized men must agree to use a barrier method of contraception during treatment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (95)

Texas Cancer Center (Dallas Southwest)

🇺🇸

Dallas, Texas, United States

Comprehensive Cancer Centers of Nevada

🇺🇸

Las Vegas, Nevada, United States

Oncology/Hematology Care, Inc.

🇺🇸

Cincinnati, Ohio, United States

University of Tennessee

🇺🇸

Knoxville, Tennessee, United States

Kansas City Cancer Center, LLC

🇺🇸

Overland Park, Kansas, United States

Hematology Oncology Associates

🇺🇸

Phoenix, Arizona, United States

Raul R. Mena, MD

🇺🇸

Burbank, California, United States

Ocala Oncology Center

🇺🇸

Ocala, Florida, United States

Cancer and Blood Disease Center

🇺🇸

Lecanto, Florida, United States

Southwest Cancer Care Medical Group

🇺🇸

Poway, California, United States

Jeffrey H. Margolis, MD

🇺🇸

Royal Oak, Michigan, United States

Minnesota Oncology Hematology, PA

🇺🇸

Minneapolis, Minnesota, United States

Chesapeake Oncology Hematology Associates (Tate Center)

🇺🇸

Glen Burnie, Maryland, United States

Associated Physicians and Surgeons, LLC

🇺🇸

Terre Haute, Indiana, United States

Hematology Oncology Associates of Illinois

🇺🇸

Chicago, Illinois, United States

Eugene Paschold, MD

🇺🇸

Winston Salem, North Carolina, United States

Warren Paroly, MD

🇺🇸

Oceanside, California, United States

Lucio Gordan, MD

🇺🇸

Gainesville, Florida, United States

Arnett Cancer Center

🇺🇸

Lafayette, Indiana, United States

Dayton Oncology & Hematology, PA

🇺🇸

Kettering, Ohio, United States

Puget Sound Cancer Centers

🇺🇸

Seattle, Washington, United States

Texas Oncology Cancer Center

🇺🇸

Austin, Texas, United States

New York Oncology Hematology, PC

🇺🇸

Albany, New York, United States

Texas Oncology Cancer Center--Sugar Land

🇺🇸

Sugar Land, Texas, United States

Hematology Oncology Consultants

🇺🇸

Royal Oak, Michigan, United States

William Beaumont Hospital

🇺🇸

Troy, Michigan, United States

Kentucky Cancer Clinic

🇺🇸

Hazard, Kentucky, United States

Mercy Medical Center

🇺🇸

Baltimore, Maryland, United States

Cancer Center of Florida

🇺🇸

Ocoee, Florida, United States

HUX Cancer Center/Union Hospital

🇺🇸

Terre Haute, Indiana, United States

Joliet Oncology-Hematology Associates

🇺🇸

Joliet, Illinois, United States

Rittenhouse Hematology Oncology Associates

🇺🇸

Philadelphia, Pennsylvania, United States

Texas Cancer Center

🇺🇸

Arlington, Texas, United States

St. Joseph Oncology, Inc.

🇺🇸

St. Joseph, Missouri, United States

Cancer Care Associates, PC

🇺🇸

Royal Oak, Michigan, United States

Medical Oncology Associates of Wyoming Valley, PC

🇺🇸

Kingston, Pennsylvania, United States

Paoli Hospital

🇺🇸

Paoli, Pennsylvania, United States

Texas Cancer Center / Denton

🇺🇸

Denton, Texas, United States

Texas Oncology, PA

🇺🇸

Mesquite, Texas, United States

US Oncology Research and Clinical Pharmacy

🇺🇸

Ft. Worth, Texas, United States

Virginia Oncology Associates

🇺🇸

Norfolk, Virginia, United States

Luke Walker, MD

🇺🇸

Everett, Washington, United States

Cascade Cancer Center

🇺🇸

Kirkland, Washington, United States

Oncology & Hematology Associates of Southwest Virginia

🇺🇸

Salem, Virginia, United States

Bux-Mont Oncology-Hematology

🇺🇸

Sellersville, Pennsylvania, United States

Tyler Cancer Center

🇺🇸

Tyler, Texas, United States

Northwestern Carolina Oncology & Hematology, PA

🇺🇸

Hickory, North Carolina, United States

Satish A. Shah, MD

🇺🇸

Gettysburg, Pennsylvania, United States

Hematology-Oncology Group, PC

🇺🇸

Langhorne, Pennsylvania, United States

Pottstown Memorial Medical Center

🇺🇸

Pottstown, Pennsylvania, United States

Joe Arrington Cancer Research and Treatment Center

🇺🇸

Lubbock, Texas, United States

St. Mary Medical Center--Research Center

🇺🇸

Langhorne, Pennsylvania, United States

West Texas Cancer Center

🇺🇸

Odessa, Texas, United States

Mary Crowley Medical Research Center

🇺🇸

Dallas, Texas, United States

Paris Regional Cancer Center

🇺🇸

Paris, Texas, United States

Texas Oncology, PA / Allison Cancer Center

🇺🇸

Midland, Texas, United States

Cancer Outreach Associates, PC / Outreach Clinical Trial Consortium LLC

🇺🇸

Abingdon, Virginia, United States

Cancer Care Northwest

🇺🇸

Spokane, Washington, United States

Virginia Physicians, Inc.

🇺🇸

Richmond, Virginia, United States

Pacific Coast Hematology / Oncology Medical Group, Inc.

🇺🇸

Fountain Valley, California, United States

Heritage Physician Group-Oncology

🇺🇸

Hot Springs, Arkansas, United States

Robert A. Moss, MD, FACP, Inc.

🇺🇸

Fountain Valley, California, United States

Marshall Schreeder, MD

🇺🇸

Huntsville, Alabama, United States

Antelope Valley Cancer Center

🇺🇸

Lancaster, California, United States

Northeast Georgia Cancer Care, LLC

🇺🇸

Athens, Georgia, United States

North Idaho Cancer Center

🇺🇸

Coeur d'Alene, Idaho, United States

Fallon Clinic, Inc. at Worcester Medical Center

🇺🇸

Worcester, Massachusetts, United States

American Health Network of Indiana--Hematology/Oncology

🇺🇸

Indianapolis, Indiana, United States

Northern Indiana Oncology Associates

🇺🇸

South Bend, Indiana, United States

Cancer Care Associates

🇺🇸

Tulsa, Oklahoma, United States

Carroll County Cancer Center

🇺🇸

Westminster, Maryland, United States

Youssef Hanna, MD

🇺🇸

Port Huron, Michigan, United States

Michael McKenzie, DO

🇺🇸

Clinton Township, Michigan, United States

Cancer and Transplant Consultants, PLC

🇺🇸

Rochester Hills, Michigan, United States

Dr. Folbe, MD/PC

🇺🇸

Troy, Michigan, United States

McLeod Cancer and Blood Center

🇺🇸

Johnson City, Tennessee, United States

El Paso Cancer Treatment Center--East

🇺🇸

El Paso, Texas, United States

Grandview Hospital

🇺🇸

Sellersville, Pennsylvania, United States

Associates in Oncology and Hematology

🇺🇸

Chattanooga, Tennessee, United States

Fairfax Northern Virginia Hematology / Oncology, PC

🇺🇸

Fairfax, Virginia, United States

Northwest Cancer Specialists, PC

🇺🇸

Vancouver, Washington, United States

Medical Consultants, Ltd.

🇺🇸

Milwaukee, Wisconsin, United States

Piedmont Hematology Oncology / Winston-Salem

🇺🇸

Winston-Salem, North Carolina, United States

Mile High Oncology

🇺🇸

Denver, Colorado, United States

Charleston Hematology Oncology, PA

🇺🇸

Charleston, South Carolina, United States

Palmetto Hematology Oncology PC

🇺🇸

Spartanburg, South Carolina, United States

Mercer Bucks Oncology/Hematology

🇺🇸

Trenton, New Jersey, United States

VA Sierra Nevada Health Care System

🇺🇸

Reno, Nevada, United States

Medical Specialists of Fairfield

🇺🇸

Fairfield, Connecticut, United States

Capital Health System

🇺🇸

Trenton, New Jersey, United States

Northwestern Connecticut Oncology Hematology Associates, LLP

🇺🇸

Torrington, Connecticut, United States

Cancer Care Institute of Carolina

🇺🇸

Aiken, South Carolina, United States

Hunterdon Regional Cancer Center

🇺🇸

Flemington, New Jersey, United States

Monmouth Medical Center

🇺🇸

Long Branch, New Jersey, United States

Hematology Oncology Associates, SJ, PA

🇺🇸

Mount Holly, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath